Just in case some readers of your post are misled by other comments, the FDA approval that you refer to is, of course, for the Pivotal Study IDE - the one that BARDA has paid $15M USD to Polynovo for.
PNV - Chart, page-7391
-
- There are more pages in this discussion • 11,723 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PNV (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$2.29 |
Change
-0.010(0.43%) |
Mkt cap ! $1.580B | |||
| Open | High | Low | Value | Volume |
| $2.33 | $2.34 | $2.24 | $2.151M | 944.0K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 9090 | $2.27 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.29 | 15253 | 5 |
View Market Depth
| Last trade - 16.10pm 15/07/2024 (20 minute delay) ? |
| PNV (ASX) Chart |